HC Wainwright downgraded shares of RAPT Therapeutics (NASDAQ:RAPT – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Wednesday morning, Marketbeat reports. Several other research firms have also recently commented on RAPT. JPMorgan Chase & Co. increased their target price on RAPT Therapeutics from $32.00 to […]
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its target price boosted by equities research analysts at Royal Bank of Canada from $57.00 to $66.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank of Canada’s price objective would indicate […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) CEO Samarth Kulkarni sold 6,370 shares of CRISPR Therapeutics stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $79.67, for a total value of $507,497.90. Following the sale, the chief executive officer now owns 194,257 shares in […]
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price objective hoisted by analysts at Needham & Company LLC from $88.00 to $90.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price objective indicates a potential upside of 8.41% […]
CARGO Therapeutics, Inc. (NASDAQ:CRGX – Get Free Report) shares shot up 3.4% during mid-day trading on Tuesday . The stock traded as high as $23.08 and last traded at $22.95. 16,462 shares were traded during trading, a decline of 88% from the average session volume of 139,698 shares. The stock had previously closed at $22.20. […]